| Proteomics identifies new therapeutic targets of early-stage hepatocellular carcinoma Y Jiang, A Sun, Y Zhao, W Ying, H Sun, X Yang, B Xing, W Sun, L Ren, ... Nature 567 (7747), 257-261, 2019 | 660 | 2019 |
| High expression of macrophage colony-stimulating factor in peritumoral liver tissue is associated with poor survival after curative resection of hepatocellular carcinoma XD Zhu, JB Zhang, PY Zhuang, HG Zhu, W Zhang, YQ Xiong, WZ Wu, ... Journal of clinical oncology 26 (16), 2707-2716, 2008 | 629 | 2008 |
| Depletion of tumor-associated macrophages enhances the effect of sorafenib in metastatic liver cancer models by antimetastatic and antiangiogenic effects W Zhang, XD Zhu, HC Sun, YQ Xiong, PY Zhuang, HX Xu, LQ Kong, ... Clinical Cancer Research 16 (13), 3420-3430, 2010 | 400 | 2010 |
| Modulation of M2 macrophage polarization by the crosstalk between Stat6 and Trim24 T Yu, S Gan, Q Zhu, D Dai, N Li, H Wang, X Chen, D Hou, Y Wang, Q Pan, ... Nature communications 10 (1), 4353, 2019 | 237 | 2019 |
| Human hepatocellular carcinoma tumor–derived endothelial cells manifest increased angiogenesis capability and drug resistance compared with normal endothelial cells YQ Xiong, HC Sun, W Zhang, XD Zhu, PY Zhuang, JB Zhang, L Wang, ... Clinical Cancer Research 15 (15), 4838-4846, 2009 | 225 | 2009 |
| Activation of β-catenin by hypoxia in hepatocellular carcinoma contributes to enhanced metastatic potential and poor prognosis L Liu, XD Zhu, WQ Wang, Y Shen, Y Qin, ZG Ren, HC Sun, ZY Tang Clinical cancer research 16 (10), 2740-2750, 2010 | 216 | 2010 |
| miR-182-5p promotes hepatocellular carcinoma progression by repressing FOXO3a MQ Cao, AB You, XD Zhu, W Zhang, YY Zhang, SZ Zhang, K Zhang, ... Journal of hematology & oncology 11, 1-12, 2018 | 199 | 2018 |
| Positive serum hepatitis B e antigen is associated with higher risk of early recurrence and poorer survival in patients after curative resection of hepatitis B-related … HC Sun, W Zhang, LX Qin, BH Zhang, QH Ye, L Wang, N Ren, PY Zhuang, ... Journal of hepatology 47 (5), 684-690, 2007 | 195 | 2007 |
| Downstaging and resection of initially unresectable hepatocellular carcinoma with tyrosine kinase inhibitor and anti-PD-1 antibody combinations XD Zhu, C Huang, YH Shen, Y Ji, NL Ge, XD Qu, L Chen, WK Shi, ML Li, ... Liver cancer 10 (4), 320-329, 2021 | 150 | 2021 |
| MicroRNA-26a inhibits angiogenesis by down-regulating VEGFA through the PIK3C2α/Akt/HIF-1α pathway in hepatocellular carcinoma ZT Chai, J Kong, XD Zhu, YY Zhang, L Lu, JM Zhou, LR Wang, KZ Zhang, ... PloS one 8 (10), e77957, 2013 | 145 | 2013 |
| Colony-stimulating factor 1 receptor blockade inhibits tumor growth by altering the polarization of tumor-associated macrophages in hepatocellular carcinoma JY Ao, XD Zhu, ZT Chai, H Cai, YY Zhang, KZ Zhang, LQ Kong, N Zhang, ... Molecular cancer therapeutics 16 (8), 1544-1554, 2017 | 143 | 2017 |
| Sorafenib down-regulates expression of HTATIP2 to promote invasiveness and metastasis of orthotopic hepatocellular carcinoma tumors in mice W Zhang, HC Sun, WQ Wang, QB Zhang, PY Zhuang, YQ Xiong, XD Zhu, ... Gastroenterology 143 (6), 1641-1649. e5, 2012 | 117 | 2012 |
| The clinical significance of the CD163+ and CD68+ macrophages in patients with hepatocellular carcinoma LQ Kong, XD Zhu, HX Xu, JB Zhang, L Lu, WQ Wang, QB Zhang, WZ Wu, ... PloS one 8 (3), e59771, 2013 | 104 | 2013 |
| microRNA-26a suppresses recruitment of macrophages by down-regulating macrophage colony-stimulating factor expression through the PI3K/Akt pathway in hepatocellular carcinoma ZT Chai, XD Zhu, JY Ao, WQ Wang, DM Gao, J Kong, N Zhang, YY Zhang, ... Journal of hematology & oncology 8, 1-11, 2015 | 91 | 2015 |
| Emerging agents and regimens for hepatocellular carcinoma XD Zhu, HC Sun Journal of hematology & oncology 12 (1), 110, 2019 | 90 | 2019 |
| Chinese expert consensus on conversion therapy for hepatocellular carcinoma (2021 edition) HC Sun, J Zhou, Z Wang, X Liu, Q Xie, W Jia, M Zhao, X Bi, G Li, X Bai, ... Hepatobiliary surgery and nutrition 11 (2), 227, 2022 | 87 | 2022 |
| Two pathologic types of hepatocellular carcinoma with lymph node metastasis with distinct prognosis on the basis of CK19 expression in tumor PY Zhuang, JB Zhang, XD Zhu, W Zhang, WZ Wu, YS Tan, J Hou, ... Cancer: Interdisciplinary International Journal of the American Cancer …, 2008 | 84 | 2008 |
| CD31 regulates metastasis by inducing epithelial–mesenchymal transition in hepatocellular carcinoma via the ITGB1-FAK-Akt signaling pathway YY Zhang, LQ Kong, XD Zhu, H Cai, CH Wang, WK Shi, MQ Cao, XL Li, ... Cancer letters 429, 29-40, 2018 | 80 | 2018 |
| Tanshinone IIA inhibits metastasis after palliative resection of hepatocellular carcinoma and prolongs survival in part via vascular normalization WQ Wang, L Liu, HC Sun, YL Fu, HX Xu, ZT Chai, QB Zhang, LQ Kong, ... Journal of hematology & oncology 5, 1-11, 2012 | 73 | 2012 |
| Targeting angiogenesis for liver cancer: past, present, and future XD Zhu, ZY Tang, HC Sun Genes & Diseases 7 (3), 328-335, 2020 | 72 | 2020 |
